| Hydralazine hydrochloride |
盐酸肼屈嗪 |
304-20-1 |
| 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]- |
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]- |
2140807-23-2 |
| BMS-1001 |
BMS-1001 |
2113650-04-5 |
| CDK9-PROTAC |
N-(5-环丁基-1H-吡唑-3-基)-2-(4-((5-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)戊基)氧基)苯基)乙酰胺 |
2118356-96-8 |
| CPI-455 Hydrochloride |
CPI-455 Hydrochloride |
2095432-28-1 |
| A1874 |
A-1874;A 1874 |
2064292-12-0 |
| LY 303511 (hydrochloride) |
CS-1207 |
2070014-90-1 |
| Thalidomide-O-amido-C3-NH2 (TFA) |
Thalidomide-O-amido-C3-NH2 (TFA) |
2022182-58-5 |
| 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2,2'-(iminodi-2,1-ethanediyl)bis- |
化合物M-31850 |
281224-40-6 |
| GR148672X |
GR148672X |
263890-70-6 |
| CCG-1423 |
CCG1423 |
285986-88-1 |
| 5-[4-PHENYL-5-(TRIFLUOROMETHYL)-2-THIENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOLE |
5-[4-苯基-5-(三氟甲基)-2-噻吩基]-3-[3-(三氟甲基)苯基]-1,2,4-恶二唑 |
256414-75-2 |
| M344 |
4-(二甲氨基)-N-[7-(羟基氨基)-7-氧庚]苯甲酰胺 |
251456-60-7 |
| Udenafil |
乌地那非 |
268203-93-6 |
| H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH |
NFAT INHIBITOR |
249537-73-3 |
| ATN-161 |
262438-43-7 |
262438-43-7 |
| 4-AMINO-1-TERT-BUTYL-3-(1'-NAPHTHYL)PYRAZOLO[3,4-D]PYRIMIDINE |
4 -氨基- 1 -叔丁基- 3 -(1' -萘基)吡唑并[3,4 - D]嘧啶 |
221243-82-9 |
| 1 NM-PP1 |
4-氨基1-叔丁基-3-(1'-萘甲基)吡唑并[3,4-D]嘧啶 |
221244-14-0 |
| MPEP HYDROCHLORIDE |
2-甲基-6-(苯基乙炔基)吡啶盐酸盐 |
219911-35-0 |
| 5,5'-(2,5-FURANDIYL)BIS-2-THIOPHENEMETHANOL |
5,5'-(2,5-呋喃二基)二-2-噻吩甲醇 |
213261-59-7 |
QQ
微信
